BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles
GlobeNewswire
PRESS RELEASE - PRIVILEGED INFORMATION
*Mont-Saint-Guibert, Belgium, 26 April 2024, 17:30 CET – **BioSenic**..
Phase One (company)
News and Video Search Results
News coverage
-
Green Energy Expo 2024: Sungrow Unveils its Innovative Solar-Plus-Storage Solutions to Facilitate South Korea's Energy Transition
PR Newswire Asia
-
UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
GlobeNewswire
-
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
GlobeNewswire
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
GlobeNewswire
0 shares
1 views
You might like
Phase One (company) media coverage
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
GlobeNewswire
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer..
-
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
GlobeNewswire
-
Nel ASA: Hy Stor Energy places gigawatt capacity reservation for Mississippi Clean Hydrogen Hub
GlobeNewswire
-
Transitional Care Management Services Market To Reach USD 962.1 Billion By 2032, Says DataHorizzon Research
GlobeNewswire
-
Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire
Advertisement
More coverage
【Press Release】China XLX Announces 2024 1Q Results
EQS Group
EQS Newswire / 26/04/2024 / 13:17 UTC+8Press Release
(For immediate release)
China XLX Announces 2024 1Q..
-
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
EQS Group
-
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
GlobeNewswire
-
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
PR Newswire Asia
-
Eldorado Gold Reports First Quarter 2024 Financial and Operational Results; Steady Start to 2024
GlobeNewswire